Wolff Wiese Magana’s Ionis Pharmaceuticals IONS Stock Holding History

Wolff Wiese Magana’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-41	Closed	-$1.24K	–	1020
2025 Q1	$1.24K	Hold	41	–	–	﹤0.01%	822
2024 Q4	$1.43K	Sell	41 -69	-63%	-$2.58K	﹤0.01%	759
2024 Q3	$4.41K	Buy	+110	New	+$5.12K	﹤0.01%	605
2022 Q4	–	Sell	-910	Closed	-$40K	–	875
2022 Q3	$40K	Sell	910 -164	-15%	-$6.91K	0.03%	267
2022 Q2	$40K	Sell	1,074 -57	-5%	-$2.15K	0.03%	289
2022 Q1	$42K	Hold	1,131	–	–	0.03%	300
2021 Q4	$35K	Hold	1,131	–	–	0.02%	326
2021 Q3	$38K	Hold	1,131	–	–	0.03%	319
2021 Q2	$45K	Hold	1,131	–	–	0.03%	293
2021 Q1	$51K	Hold	1,131	–	–	0.04%	271
2020 Q4	$64K	Buy	+1,131	New	+$56.4K	0.05%	226

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Wolff Wiese Magana's IONS Position: Q2 2025 in Review

Wolff Wiese Magana sold out of Ionis Pharmaceuticals (IONS) in Q2 2025, closing a stake of 41 shares — an estimated $1.24K sold.

Wolff Wiese Magana first reported a position in IONS in Q4 2020 and held it in 11 quarters. The position peaked at $64K in Q4 2020. 362 funds tracked by Wall St. Rank hold IONS as of Q2 2025.

Wolff Wiese Magana reported no remaining Ionis Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
Wolff Wiese Magana sold 41 Ionis Pharmaceuticals shares in Q2 2025, an estimated $1.24K.
Wolff Wiese Magana first reported a position in Ionis Pharmaceuticals in Q4 2020 and held it in 11 quarters.
Wolff Wiese Magana's Ionis Pharmaceuticals position peaked at $64K in Q4 2020.
362 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2025.

Based on Wolff Wiese Magana's 13F filing for Q2 2025, filed 17 Jul 2025.